Inogen to Report Q2 Earnings on Aug. 6
Inogen (Nasdaq: INGN) will announce its second-quarter 2024 financial results in a conference call starting at 5 p.m. Eastern on Aug. 6.
Join the live conference call by dialing in as noted on Inogen’s website. An archived version of the conference call will be available on the investor relations website approximately three hours after the live event ends.
FDA Continues to Evaluate Reports on OLA+ Device Interruptions
The U.S. Food & Drug Administration (FDA) said in a July 16 announcement that it is “continuing its evaluation of the number of reports” associated with the Philips Respironics OmniLab Advanced + (OLA+) system.
In April, Philips sent OLA+ users an urgent medical device recall related to its Ventilator Inoperative Alarm. Philips has since updated instructions on using the OLA+ because of the alarm failure, “which can cause therapy interruption or loss,” the FDA announcement said. The recall is related to the instructions, not to the device itself.
Philips describes the OLA+ as a “full-featured, enhanced and robust titration system” with two CPAP modes, plus additional bi-level modes.
